Personal stories

Check out this infographic breakdown of the company’s full-year performance, with highlights from its Innovative Medicine and MedTech businesses.

Learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.

More than 200 conditions are classified as rheumatic diseases, and they tend to affect the joints and connective tissues. Here’s what a doctor wants you to know about the different types, symptoms and risk factors—and how Johnson & Johnson is innovating new treatments.

Biologics, a class of medications derived from living organisms, treat a range of conditions including immune-mediated diseases and cancer. Learn how Johnson & Johnson is innovating in biologics to improve treatment options for people around the world.

J&J CareCommunity is empowering communities to address one of the most significant barriers to ending tuberculosis (TB): underdiagnosis.

Samatha Curtis from The Good Economy shares four recommendations for impact investors.

Newsletter December 2025

By advancing innovative teleradiology solutions, more patients receive the critical imaging interpretations they need—when and where they need them most.

By investing in health workers and local infrastructure, J&J CareCommunity is helping strengthen communities and expand access to care across Latin America.

With the acquisition, more health workers across the U.S. will be able to access a comprehensive learning platform to develop new skills.